Johan Bussink Selected Research

Lung Neoplasms (Lung Cancer)

1/2021	Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy.
3/2020	Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO in silico study.
1/2020	Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.
11/2016	The Impact of Optimal Respiratory Gating and Image Noise on Evaluation of Intratumor Heterogeneity on 18F-FDG PET Imaging of Lung Cancer.
1/2016	Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology.
10/2013	Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients.
2/2006	Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johan Bussink Research Topics

Disease

100	Neoplasms (Cancer) 05/2024 - 09/2002
75	Hypoxia (Hypoxemia) 05/2024 - 12/2002
37	Squamous Cell Carcinoma of Head and Neck 01/2022 - 09/2002
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2020 - 07/2007
20	Head and Neck Neoplasms (Head and Neck Cancer) 10/2022 - 12/2002
14	Carcinoma (Carcinomatosis) 11/2017 - 12/2002
13	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2007
12	Breast Neoplasms (Breast Cancer) 02/2020 - 08/2011
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2018 - 04/2003
7	Lung Neoplasms (Lung Cancer) 01/2021 - 02/2006
5	Necrosis 01/2022 - 07/2006
4	Adenocarcinoma 12/2019 - 06/2012
4	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 02/2005
3	Laryngeal Neoplasms (Laryngeal Cancer) 03/2014 - 10/2013
2	Atherosclerosis 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2020 - 01/2019
2	Starvation 01/2018 - 08/2011
2	Triple Negative Breast Neoplasms 01/2015 - 10/2011
2	Sarcoma (Soft Tissue Sarcoma) 08/2012 - 06/2012
1	Melanoma (Melanoma, Malignant) 05/2024
1	Colonic Neoplasms (Colon Cancer) 05/2024
1	Thyroid Nodule (Nodule, Thyroid) 01/2023
1	Thyroid Neoplasms (Thyroid Cancer) 01/2023

Drug/Important Bio-Agent (IBA)

29	pimonidazoleIBA 01/2023 - 09/2002
25	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2008
18	Carbonic Anhydrase IXIBA 01/2023 - 12/2002
16	ErbB Receptors (EGF Receptor)IBA 01/2016 - 06/2009
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2008
12	Messenger RNA (mRNA)IBA 01/2022 - 08/2011
11	carbogenIBA 01/2022 - 12/2002
10	Oxygen (Dioxygen)IBA 05/2024 - 09/2002
10	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 06/2007
10	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2022 - 06/2002
10	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017 - 06/2008
9	Cetuximab (Erbitux)FDA Link 01/2016 - 08/2011
9	Phosphotransferases (Kinase)IBA 06/2015 - 06/2009
6	Pentetic Acid (DTPA)FDA LinkGeneric 10/2022 - 08/2011
5	Tamoxifen FDA LinkGeneric 05/2024 - 02/2014
5	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 05/2012 - 09/2002
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2007
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
4	Radioisotopes (Radionuclides)IBA 01/2022 - 07/2010
4	MK 2206IBA 01/2020 - 10/2012
4	alovudineIBA 04/2013 - 05/2007
4	fluoroazomycin arabinosideIBA 09/2009 - 03/2008
4	CCI 103FIBA 02/2007 - 09/2004
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022 - 01/2010
3	Glutamine (L-Glutamine)FDA Link 01/2022 - 12/2018
3	Hypoxia-Inducible Factor 1IBA 01/2022 - 08/2011
3	G250 monoclonal antibodyIBA 07/2021 - 01/2019
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 12/2019 - 02/2014
3	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 12/2019 - 06/2012
3	beta-Aminoethyl Isothiourea (AET)IBA 11/2018 - 10/2015
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 09/2014 - 03/2008
3	Crystallins (Crystallin)IBA 04/2014 - 03/2013
3	ParaffinIBA 09/2013 - 05/2010
3	Small Interfering RNA (siRNA)IBA 09/2013 - 08/2011
2	Atovaquone (Mepron)FDA Link 05/2024 - 07/2021
2	ElementsIBA 05/2024 - 03/2008
2	Deoxyglucose (2 Deoxy D glucose)IBA 01/2023 - 02/2006
2	RadiopharmaceuticalsIBA 01/2022 - 07/2010
2	AntibodiesIBA 01/2022 - 01/2019
2	CytokinesIBA 01/2022 - 01/2020
2	InterferonsIBA 01/2021 - 01/2018
2	Estrogen ReceptorsIBA 02/2020 - 10/2011
2	mouse dectin-2IBA 01/2020 - 01/2019
2	C-Type Lectins (C-Type Lectin)IBA 01/2020 - 01/2019
2	GlutaminaseIBA 12/2019 - 12/2018
2	Contrast MediaIBA 01/2018 - 11/2017
2	Chloroquine (Aralen)FDA LinkGeneric 01/2018 - 09/2013
2	Monoclonal AntibodiesIBA 08/2015 - 07/2010
2	Lysosomal Membrane ProteinsIBA 06/2015 - 09/2013
2	MicroRNAs (MicroRNA)IBA 03/2015 - 01/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014 - 11/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2014 - 03/2013
2	Growth Factor ReceptorsIBA 11/2013 - 03/2013
2	VimentinIBA 10/2013 - 06/2011
2	Cadherins (E-Cadherin)IBA 10/2013 - 06/2011
2	Epidermal Growth Factor (EGF)IBA 09/2013 - 01/2007
2	Activating Transcription Factor 4IBA 09/2013 - 01/2013
2	Indicators and Reagents (Reagents)IBA 06/2013 - 04/2013
2	Adenosine Triphosphate (ATP)IBA 06/2012 - 06/2008
2	NitroimidazolesIBA 07/2010 - 12/2002
2	Idoxuridine (Stoxil)FDA LinkGeneric 05/2010 - 05/2007
2	fluoromisonidazoleIBA 10/2008 - 08/2006
1	Metformin (Glucophage)FDA LinkGeneric 05/2024
1	triphenylphosphoniumIBA 05/2024
1	Green Fluorescent ProteinsIBA 05/2024
1	IACS-010759IBA 05/2024
1	AcidsIBA 01/2023
1	EnzymesIBA 01/2023
1	sodium-iodide symporter (sodium iodide symporter)IBA 01/2023
1	Bromodeoxyuridine (BrdU)IBA 01/2022

Therapy/Procedure

74	Radiotherapy 05/2024 - 06/2002
45	Therapeutics 10/2022 - 12/2002
11	Drug Therapy (Chemotherapy) 01/2019 - 09/2004
10	Aftercare (After-Treatment) 01/2018 - 09/2004
5	Immunotherapy 05/2024 - 11/2019
4	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2019 - 12/2016
4	Chemoradiotherapy 11/2018 - 04/2013